Glancy Prongay Wolke & Rotter Continues Securities Fraud Probe Into GE HealthCare Technologies

LOS ANGELES, July 8. Glancy Prongay Wolke & Rotter LLP said it is continuing a securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of the company's investors, urging shareholders who reported losses to contact the firm.

Investigation status

The Los Angeles firm described itself in the release as a leading national shareholder rights law firm. The probe is being conducted on behalf of GE HealthCare investors, the release said. No specific conduct was identified, no timeframe was given, and the nature of the alleged violations was not disclosed.

The firm's use of "continues" signals the investigation predates the July 8 announcement. No court filings were disclosed and no findings of wrongdoing have been established.

What shareholders are being asked to do

Investors in GE HealthCare Technologies who sustained losses are being urged to reach out to Glancy Prongay Wolke & Rotter directly, according to the release. The firm set no deadline for investors to come forward and disclosed no count of those who have already made contact.

GE HealthCare Technologies Inc. trades on the Nasdaq under the ticker GEHC.

Note: The source release provides limited factual detail. This article reflects only what was disclosed; no figures, allegations, or timelines were available to report.